NOT-TR-20-016
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-20-272. Due Date: applications will be accepted on a rolling basis from May 15, 2020 through January 25, 2022.
|
NOT-TR-20-017
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-20-135.
Due Date: applications will be accepted on a rolling basis from May 15, 2020 to January 25, 2022.
|
NOT-DC-20-008
| Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
| NIDCD
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
- PA-18-334 - NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-184 – NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Due Date: This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022
|
NOT-AI-20-065
| Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
| NIAID
|
Applications in response to this NOSI must be submitted using PAR-18-633 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) (or its subsequent reissued equivalents). Due Date: September 14, 2020; October 14, 2020; November 14, 2020; December 14, 2020; January 14, 2021; February 14, 2021; March 14, 2021; April 14, 2021; May 14, 2021; June 14, 2021; July 14, 2021; ; August 14, 2021; and September 14, 2021. |
NOT-MD-20-025
|
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
| NIMHD
NCI
NIDA
NLM
NIMH
NIAMS
The following NIH Offices may co-fund applications assigned to those I/Cs:
ODP
OBSSR
| Submit applications for this initiative using the following funding opportunity announcement (FOA) or any reissue of thid announcement through the expiration date of this notice:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: this notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through May 8, 2023.
|
NOT-HL-20-814
| Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
| NHLBI
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
- PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-185 Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: Applications will be accepted dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 of reissued FOAs.
|
NOT-MD-21-008
| Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
| NCI
NHLBI
NIAAA
NIAID
NIAMS
NIDA
NIDCR
NIMH
NINR
The following NIH Offices may co-fund applications assigned to those I/Cs:
OBSSR
ODP
ORWH
NIMHD
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent:
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: The first available due date is Feburary 5, 2021. Applications can be submitted through January 7, 2022.
|
NOT-MH-21-120
|
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
| NIMH
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-20-272. Due Date: Applications will be accepted for due dates on or after January 5, 2021 with rolling receipt through June 1, 2023. |
NOT-DA-20-084
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21Clinical Trial Not Allowed)
|
NOT-TR-21-022
|
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
| NCATS
| CTSA (CTRI) award specific. Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent PA-20-135. Due Date: Applications will be accepted immediately and on a rolling basis through August 16, 2024.
|
NOT-AR-21-012
|
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
| NIAMS
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PAR-21-055 - Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- PAR-21-054 - Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- PAR-21-053 - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after February 5, 2021 and subsequent receipt dates through November 18, 2021. |
NOT-DA-21-011
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
- PA-20-146 - NIDA Small Research Grant Program (R03 Clinical Trial Required)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through September 8, 2024.
|
NOT-AG-21-015
| Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
| NIA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PAR-19-374 - Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
- PAR-19-314 - NIA Program Project Applications (P01 Clinical Trial Optional)
- PAR-19-070 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
- PAR-19-071 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
- PAR-20-070 - Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
Due Date: Applications will be accepted for due dates on or after March 4, 2021 and subsequent receipt dates through May 7, 2023.
|
NOT-AG-21-016
| Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
| NIA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through May 7, 2023.
|
NOT-GM-21-019
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
| NIGMS
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent:
PA-18-935. Due Date: Applications will be accepted on a rolling basis from March 15, 2021 to December 15, 2021.
|
NOT-DA-21-019
| Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-DA-21-017
| Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
Due Date: Applications will be accepted for due dates on or after May 5, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-AI-21-008
| Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)
| NIAID
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through January 7, 2023.
|
NOT-DA-21-018
| Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-DA-21-041
| Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
| NIDA
| Applications for this initiative must be submitted using one of the following opportunity announcements or the subsequent reissued equivalent. PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. Due Date: Applications will be accepted on a rolling basis through March 31, 2022.
|
NOT-DE-21-001
| Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
| NIDCR
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023.
|
NOT-TR-21-017
| Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
| NCATS
| CTSA (CTRI) award specific. Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent PA-20-272. Due Date: Applications will be accepted immediately and on a rolling basis through August 16, 2024.
|
NOT-AI-21-057
| Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
| NIAID
NIMH
NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- Only NIAID and NIDA will accept applications for this NOSI.
Due Date: Applications will be accepted for due dates on or after September 7, 2021 and subsequent receipt dates through May 7, 2024.
|
NOT-HD-21-038
| Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities
| NICHD
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-21-221 - NICHD Small Research Grant Program (R03 Clinical Trial Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
|
NOT-HD-21-037
| Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19
| NICHD
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalents:- PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- PA-18-935 - Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -Clinical Trial Optional)
Due Date: AIDS Application Due Date(s) – September 7, 2021, January 7, 2022, May 7, 2022. |
NOT-MH-21-330
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
| NIMH
NEI
NIDA
NIAAA
NINR
NIDCR
NIMHD
NICHD
NIDCD
NIA
NCCIH
The following NIH Offices may co-fund applications assigned to those I/Cs:
ODP
ORWH
SGMRO
OBSSR
| Applicants must select the IC and associated FOA to use for submission of an application in response to the NOSI.
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- NIMH, NIDCR, NCCIH,NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIMH, NIDCR, NCCIH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PAR-21-130 - Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
- PAR-20-154 - Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delievered Remotely or via mHealth (R01 Clinical Trial Required)
- PAR-21-160 - NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
|
NOT-MH-21-330
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
| NIMH
NEI
NIDA
NIAAA
NINR
NIDCR
NIMHD
NICHD
NIDCD
NIA
NCCIH
The following NIH Offices may co-fund applications assigned to those I/Cs:
ODP
ORWH
SGMRO
OBSSR
| Applicants must select the IC and associated FOA to use for submission of an application in response to the NOSI.
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- NIMH, NIDCR, NCCIH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIMH, NIDCR, NCCIH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDA, NINR, and NIMHD
- PAR-21-130 - Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
- PAR-20-154 - Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delievered Remotely or via mHealth (R01 Clinical Trial Required)
- PAR-21-160 - NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Due Date: Applications will be accepted for due dates on or after October 5, 2021 and subsequent receipt dates through September 8, 2024.
|